Blog

Bodyport, a medtech company based in San Francisco, developed the Bodyport Cardiac Scale, a set of weighing scales that can non-invasively assess fluid status and heart function. The scales can detect these signals through the feet when a patient steps onto the device. 

Read the full article at: www.medgadget.com

Researchers at the RIKEN Center for Biosystems Dynamics Research in Japan have developed an AI-powered robotic system that can perform laboratory experiments in regenerative medicine, learn from the results, and perform iterative rounds of experimentation to achieve a certain goal. In a proof-of-principle, the researchers set the robot the task of optimizing cell culture conditions to create a maximal number of retinal pigment epithelium (RPE) cells. The robot improved the percentage of stem cells within a culture that differentiated into RPE cells from 50% to approximately 90% over six months of experimentation, and the researchers estimate that it would have taken humans approximately 2.5 years to achieve the same thing. 

Read the full article at: www.medgadget.com

An industry trade association is calling for global measures regarding the allocation of semiconductors during an ongoing chip shortage.

Read the full article at: www.mddionline.com

The product was subject to two FDA consumer warnings for use in medical aesthetics, but now sees clearance for neck and chin skin tightening.

Read the full article at: www.mddionline.com

TÜV SÜD Product Service, a notified body, issued the first IVDR certificate for a new device in risk class D produced by Roche Diagnostics.

Read the full article at: www.mddionline.com

In an overwhelming vote of support, the U.S. House of Representatives approved the creation of a new department within the National Institutes of Health that is focused on biomedical innovation.

Read the full article at: www.biospace.com

A new algorithm developed by researchers at Columbia University can analyze thousands of variants across the genome and estimate a person’s risk of developing chronic kidney disease-;and it works in people of African, Asian, European, and LatinX descent.

Read the full article at: www.news-medical.net

This new IVDR regulatory framework replaces the IVD Directive, under which Proscia’s Concentriq Dx also received a CE mark.

Read the full article at: www.mddionline.com

The portable platform supports diagnosis of SARS-CoV-2, influenza A, influenza B, respiratory syncytial virus, and human rhinovirus in a single test.

Read the full article at: www.360dx.com

After kicking off the year by shipping out a record number of its Tablo hemodialysis systems for at-home users, Outset Medical has brought those sales to a screeching halt.

Read the full article at: www.fiercebiotech.com